|
Volumn 10, Issue 4, 2004, Pages 563-579
|
Living lobar lung transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMPHOTERICIN B;
AZATHIOPRINE;
CYCLOSPORIN;
ENOXAPARIN;
GLYCERYL TRINITRATE;
HEPARIN;
METHOTREXATE;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NITRIC OXIDE;
PREDNISONE;
PROSTAGLANDIN E1;
TACROLIMUS;
ALLOGRAFT;
ANTIBIOTIC PROPHYLAXIS;
ARTICLE;
BRONCHIOLITIS;
CADAVER DONOR;
CAUSE OF DEATH;
CYSTIC FIBROSIS;
CYTOMEGALOVIRUS INFECTION;
FUNCTIONAL RESIDUAL CAPACITY;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOMODULATION;
LIVING DONOR;
LOW DRUG DOSE;
LUNG CANCER;
LUNG FUNCTION TEST;
LUNG HEMODYNAMICS;
LUNG INSUFFICIENCY;
LUNG LOBE;
LUNG LOBECTOMY;
LUNG RESECTION;
LUNG TRANSPLANTATION;
MORTALITY;
NONHUMAN;
ORGAN DONOR;
PATIENT SELECTION;
PNEUMOCYSTIS PNEUMONIA;
POSTOPERATIVE INFECTION;
RECIPIENT;
SURGICAL TECHNIQUE;
SURVIVAL RATE;
THROMBOEMBOLISM;
TREATMENT INDICATION;
|
EID: 10644249828
PISSN: 10785337
EISSN: None
Source Type: Journal
DOI: 10.1016/j.rcc.2004.06.004 Document Type: Review |
Times cited : (15)
|
References (32)
|